BMJ Best Practice

参考文献

关键文献

Gottstein B, Pozio E, Nockler K. Epidemiology, diagnosis, treatment, and control of trichinellosis. Clin Microbiol Rev. 2009;22:127-145.

Roy SL, Lopez AS, Schantz PM. Trichinellosis surveillance - United States, 1997-2001. MMWR Surveill Summ. 2003;52:1-8.

Wilson NO, Hall RL, Montgomery SP, et al. Trichinellosis surveillance: United States, 2008-2012. MMWR Surveill Summ. 2015;64(suppl 1):1-8.

Capo V, Despommier DD. Clinical aspects of infection with Trichinella spp. Clin Microbiol Rev. 1996;9:47-54.

Bruschi F, Murrell KD. New aspects of human trichinellosis: the impact of new trichinella species. Postgrad Med J. 2002;78:15-22.

Dupouy-Camet J, Murrell KD, eds. FAO/WHO/OIE guidelines for the surveillance, management, prevention and control of trichinellosis. 2007. http://www.fao.org/ (last accessed 7 July 2017).

Centers for Disease Control and Prevention. Parasites - Trichinellosis (also known as Trichinosis). August 2012. http://www.cdc.gov/ (last accessed 7 July 2017).

Dupouy-Camet J, Kociecka W, Bruschi F, et al. Opinion on the diagnosis and treatment of human trichinellosis. Expert Opin Pharmacother. 2002;3:1117-1130.

参考文章

1.  Pozio E, Darwin Murrell K. Systematics and epidemiology of trichinella. Adv Parasitol. 2006;63:367-439.

2.  Gottstein B, Pozio E, Nockler K. Epidemiology, diagnosis, treatment, and control of trichinellosis. Clin Microbiol Rev. 2009;22:127-145.

3.  Pozio E. New patterns of trichinella infection. Vet Parasitol. 2001;98:133-148.

4.  De Bruyne A, Ancelle T, Vallee I, et al. Human trichinellosis acquired from wild boar meat: a continuing parasitic risk in France. Euro Surveill. 2006;11:E060914.5.

5.  Centers for Disease Control and Prevention. Outbreak of trichinellosis associated with eating cougar jerky - Idaho, 1995. MMWR Morb Mortal Wkly Rep. 1996;45:205-206.

6.  Madariaga MG, Cachay ER, Zarlenga DS. A probable case of human neurotrichinellosis in the United States. Am J Trop Med Hyg. 2007;77:347-349.

7.  Barr R. Human trichinosis: report of four cases, with emphasis on central nervous system involvement, and a survey of 500 consecutive autopsies at the Ottawa Civic Hospital. Can Med Assoc J. 1966;95:912-917.

8.  Bailey T, Schantz P. Trends in the incidence and transmission patterns of trichinosis in humans in the United States: comparisons of the periods 1975-1981 and 1982-1986. Rev Infect Dis. 1990;12:5-11.

9.  Blaga R, Durand N, Antoniu S, et al. A dramatic increase in the incidence of human trichinellosis in Romania over the past 25 years: impact of political changes and regional food habits. Am J Trop Med Hyg. 2007;76:983-986.

10.  Moorhead A, Grunenwald PE, Dietz VJ, et al. Trichinellosis in the United States, 1991-1996: declining but not gone. Am J Trop Med Hyg. 1999;60:66-69.

11.  Roy SL, Lopez AS, Schantz PM. Trichinellosis surveillance - United States, 1997-2001. MMWR Surveill Summ. 2003;52:1-8.

12.  Wilson NO, Hall RL, Montgomery SP, et al. Trichinellosis surveillance: United States, 2008-2012. MMWR Surveill Summ. 2015;64(suppl 1):1-8.

13.  Dupouy-Camet, J. Trichinellosis: still a concern for Europe. Eurosurveillance. 2006;11:5.

14.  Liu M, Boireau P. Trichinellosis in China: epidemiology and control. Trends Parasitol. 2002;18:553-556.

15.  Cui J, Wang ZQ, Xu BL. The epidemiology of human trichinellosis in China during 2004-2009. Acta Trop. 2011;118:1-5.

16.  Zimmermann WJ, Steele JH, Kagan IG. Trichiniasis in the U.S. population, 1966-70. Prevalence and epidemiologic factors. Health Serv Rep. 1973;88:606-623.

17.  Akkoc N, Kuruuzum Z, Akar S, et al. Trichinellosis Outbreak Study Group. A large-scale outbreak of trichinellosis caused by Trichinella britovi in Turkey. Zoonoses Public Health. 2009;56:65-70.

18.  Neghina R. Trichinellosis, a Romanian never-ending story: an overview of traditions, culinary customs, and public health conditions. Foodborne Pathog Dis. 2010;7:999-1003.

19.  Blaxter ML, De Ley P, Garey JR, et al. A molecular evolutionary framework for the phylum nematoda. Nature. 1998;392:71-75.

20.  Lo YC, Hung CC, Lai CS, et al. Human trichinosis after consumption of soft-shelled turtles, Taiwan. Emerg Infect Dis. 2009;15:2056-2058.

21.  Takumi K, Teunis P, Fonville M, et al. Transmission risk of human trichinellosis. Vet Parasitol. 2009;159:324-327.

22.  Murrell KD, Pozio E. Trichinellosis: the zoonosis that won't go quietly. Int J Parasitol. 2000;30:1339-1349.

23.  Campbell W. Trichinosis revisited - another look at the modes of transmission. Parasitol Today. 1988; 4:83-86.

24.  Kociecka W. Trichinellosis: Proceedings of the 8th International Conference on Trichinosis, 1st ed. Rome: Istituto Superiore di Sanita Press; 1993:475-480.

25.  Pozio E, Zarlenga D, La Rosa G. The detection of encapsulated and non-encapsulated species of trichinella suggests the existence of two evolutive lines in the genus. Parasite. 2001;8:S27-S29.

26.  Virchow R. Research about the development of Trichina spiralis. R Acad Sci. 1859;49:660-662.

27.  Gould S. Trichinosis in man and animals, 1st ed. Springfield, IL: Charles C Thomas;1970:147-328.

28.  Capo V, Despommier DD. Clinical aspects of infection with Trichinella spp. Clin Microbiol Rev. 1996;9:47-54.

29.  Ancelle T. History of trichinellosis outbreaks linked to horse meat consumption 1975-1998. Euro Surveill. 1998;3:86-89.

30.  Bruschi F, Murrell KD. New aspects of human trichinellosis: the impact of new trichinella species. Postgrad Med J. 2002;78:15-22.

31.  McIntyre L, Pollock SL, Fyfe M, et al. Trichinellosis from consumption of wild game meat. CMAJ. 2007;176:449-451.

32.  Dupouy-Camet J, Murrell KD, eds. FAO/WHO/OIE guidelines for the surveillance, management, prevention and control of trichinellosis. 2007. http://www.fao.org/ (last accessed 7 July 2017).

33.  Bessonov AS, Cuperlovic K, Gajadhar AA, et al; International Commission on Trichinellosis. Recommendations on methods for the control of Trichinella in domestic and wild animals intended for human consumption. 2007. http://www.med.unipi.it/ (last accessed 7 July 2017).

34.  Centers for Disease Control and Prevention. Parasites - Trichinellosis (also known as Trichinosis). August 2012. http://www.cdc.gov/ (last accessed 7 July 2017).

35.  Larrat S, Simard M, Lair S, et al. From science to action and from action to science: the Nunavik Trichinellosis Prevention Program. Int J Circumpolar Health. 2012;71:18595.

36.  International Commission on Trichinellosis. ICT recommendations. 2015. http://www.trichinellosis.org/ (last accessed 7 July 2017).

37.  Clausen MR, Meyer CN, Krantz T, et al. Trichinella infection and clinical disease. QJM. 1996;89:631-636.

38.  Pozio E, Varese P, Morales MA, et al. Comparison of human trichinellosis caused by Trichinella spiralis and by Trichinella britovi. Am J Trop Med Hyg. 1993;48:568-575.

39.  De Bruyne A, Vallée I, Ancelle T, et al. Trichinelloses [in French]. Mal infect. 2006;8:517-A-10.

40.  Ferraccioli GF, Mercadanti M, Salaffi F, et al. Prospective rheumatological study of muscle and joint symptoms during Trichinella nelsoni infection. Q J Med. 1988;69:973-984.

41.  Hanada K, Hashimoto I, Yamaguchi T, et al. Cutaneous changes in trichinellosis seen in Japan. J Dermatol. 1987;14:586-589.

42.  Sanad MM, Salem SA, el-Dessouky KI, et al. Experimental trichinosis: effect of immunosuppression on the host-parasite system. J Egypt Soc Parasitol. 1991;21:423-438.

43.  Taybouavone T Hai TN, Odermatt P, et al. Trichinellosis during pregnancy: a case control study in the Lao Peoples' Democratic Republic. Vet Parasitol. 2009;159:332-336.

44.  Ozdemir D, Ozkan H, Akkoc N, et al. Acute trichinellosis in children compared with adults. Pediatr Infect Dis J. 2005;24:897-900.

45.  Kociecka W. Trichinellosis: human disease, diagnosis and treatment. Vet Parasitol. 2000;93:365-383.

46.  Read CP. Some physiological and biochemical aspects of host-parasite relations. J Parasitol. 1970;56:643-652.

47.  Watanabe N, Bruschi F, Korenaga M. IgE: a question of protective immunity in Trichinella spiralis infection. Trends Parasitol. 2005;21:175-178.

48.  Baron EJ, Miller JM, Weinstein MP, et al. A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2013 recommendations by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)(a). Clin Infect Dis. 2013;57:e22-e121.

49.  van Knapen F, Franchimont JH, Verdonk AR, et al. Detection of specific immunoglobulins (IgG, IgM, IgA, IgE) and total IgE levels in human trichinosis by means of the enzyme-linked immunosorbent assay (ELISA). Am J Trop Med Hyg. 1982;31:973-976.

50.  Yera H, Andiva S, Perret C, et al. Development and evaluation of a Western blot kit for diagnosis of human trichinellosis. Clin Diagn Lab Immunol. 2003;10:793-796.

51.  Piergili-Fioretti D, Castagna B, Frongillo RF, et al. Re-evaluation of patients involved in a trichinellosis outbreak caused by Trichinella britovi 15 years after infection. Vet Parasitol. 2005;132:119-123.

52.  Kreel L, Poon WS, Nainby-Luxmoore JC. Trichinosis diagnosed by computed tomography. Postgrad Med J. 1988;64:626-630.

53.  Neghina R, Neghina AM, Marincu I, et al. Reviews on trichinellosis (II): neurological involvement. Foodborne Pathog Dis. 2011;8:579-585.

54.  Puljiz I, Beus A, Kuzman I, et al. Electrocardiographic changes and myocarditis in trichinellosis: a retrospective study of 154 patients. Ann Trop Med Parasitol. 2005;99:403-411.

55.  Neghina R, Neghina AM, Marincu I, et al. Reviews on trichinellosis (I): renal involvement. Foodborne Pathog Dis. 2011;8:179-188.

56.  Neghina R, Neghina AM. Reviews on trichinellosis (IV): hepatic involvement. Foodborne Pathog Dis. 2011;8:943-948.

57.  Dupouy-Camet J, Kociecka W, Bruschi F, et al. Opinion on the diagnosis and treatment of human trichinellosis. Expert Opin Pharmacother. 2002;3:1117-1130.

58.  Harms G, Binz P, Feldmeier H, et al. Trichinosis: a prospective controlled study of patients ten years after acute infection. Clin Infect Dis. 1993;17:637-643.

59.  Guenther S, Nockler K, von Nickisch-Rosenegk M, et al. Detection of Trichinella spiralis, T. britovi and T. pseudospiralis in muscle tissue with real-time PCR. J Microbiol Methods. 2008;75:287-292.

60.  Lachkar S, Abboud P, Gargala G, et al. Troponin dosage in a patient with asymptomatic myocarditis due to trichinellosis [in French]. Rev Med Interne. 2008;29:246-248.

61.  Bessoudo R, Marrie TJ, Smith ER. Cardiac involvement in trichinosis. Chest. 1981;79:698-699.

62.  Watt G, Saisorn S, Jongsakul K, et al. Blinded, placebo-controlled trial of antiparasitic drugs for trichinosis myositis. J Infect Dis. 2000;182:371-374.

63.  Nagy J, Schipper HG, Koopmans RP, et al. Effect of grapefruit juice or cimetidine coadministration on albendazole bioavailability. Am J Trop Med Hyg. 2002;66:260-263.

64.  Pozio E, Sacchini D, Sacchi L, et al. Failure of mebendazole in the treatment of humans with Trichinella spiralis infection at the stage of encapsulating larvae. Clin Infect Dis. 2001;32:638-642.

65.  Horstmann RD, Kern P, Volkmer KJ, et al. Observations on mebendazole vs. thiabendazole in the treatment of human trichinellosis. Tropenmed Parasitol. 1982;33:191-194.

66.  Fourestie V, Bougnoux ME, Ancelle T, et al. Randomized trial of albendazole versus tiabendazole plus flubendazole during an outbreak of human trichinellosis. Parasitol Res. 1988;75:36-41.

67.  Watt G, Silachamroon U. Areas of uncertainty in the management of human trichinellosis: a clinical perspective. Expert Rev Anti Infect Ther. 2004;2:649-652.

68.  Ndibazza J, Muhangi L, Akishule D, et al. Effects of deworming during pregnancy on maternal and perinatal outcomes in Entebbe, Uganda: a randomized controlled trial. Clin Infect Dis. 2010;50:531-540.

69.  Montresor A, Stoltzfus RJ, Albonico M, et al. Is the exclusion of children under 24 months from anthelmintic treatment justifiable? Trans R Soc Trop Med Hyg. 2002;96:197-199.

70.  Jung H, Hurtado M, Medina MT, et al. Dexamethasone increases plasma levels of albendazole. J Neurol. 1990;237:279-280.

71.  Shimoni Z, Klein Z, Weiner P, et al. The use of prednisone in the treatment of trichinellosis. Isr Med Assoc J. 2007;9:537-539.

72.  el-Azzouni MZ. Effect of ivermectin on experimental trichinosis. J Egypt Soc Parasitol. 1997;27:331-340.

73.  Harder A, Schmitt-Wrede HP, Krucken J, et al. Cyclooctadepsipeptides - an anthelmintically active class of compounds exhibiting a novel mode of action. Int J Antimicrob Agents. 2003;22:318-331.

74.  Casulli A, Morales MA, Gallinella B, et al. 2-Hydroxypropyl-beta-cyclodextrin improves the effectiveness of albendazole against encapsulated larvae of Trichinella spiralis in a murine model. J Antimicrob Chemother. 2006;58:886-890.

75.  Dupouy-Camet J. Trichinellosis: a worldwide zoonosis. Vet Parasitol. 2000;93:191-200.

76.  Ursell PC, Habib A, Babchick O, et al. Myocarditis caused by Trichinella spiralis. Arch Pathol Lab Med. 1984;108:4-5.

77.  MacLean JD, Viallet J, Law C, et al. Trichinosis in the Canadian Arctic: report of five outbreaks and a new clinical syndrome. J Infect Dis. 1989;160:513-520.

78.  Faber M, Schink S, Mayer-Scholl A, et al. Outbreak of trichinellosis due to wild boar meat and evaluation of the effectiveness of post exposure prophylaxis, Germany, 2013. Clin Infect Dis. 2015;60:e98-e104.

使用此内容应接受我们的免责声明